NEET 2021: Entrance test for admission to MBBS/BDS programmes to be conducted on 1 Aug, says NTA

-

NEET 2021: The National Eligibility cum Entrance Test (NEET) for admission to undergraduate medical courses will be conducted on 1 August, the Ministry of Education's National Testing Agency (NTA) announced on Friday.

Candidates wanting to apply to MBBS/BDS programmes will be able to submit an application for the entrance examination on the official portal ntaneet.nic.in. For more details, candidates can also check the NTA's official website nta.ac.in.

"The NEET (UG), 2021, is going to be conducted by NTA for admission to MBBS, BDS, BAMS, BSMS, BUMS and BHMS courses as per the relevant norms, guidelines and regulations notified by the regulatory bodies concerned. The exam will be conducted in 11 languages, including Hindi and English, through pen and paper mode on 1 August," the NTA said in the official notification.

A bulletin with detailed information regarding the test, syllabus, eligibility criteria for age, reservation, categorisation of seats, examination fee, cities of examination, state code will be available shortly when the submission of the application form for NEET (UG) starts, it added.

The list of documents needed as part of the application form for the NEET exam is: Class 10 and Class 12 certificates and mark sheets, copy of Aadhar card, passport number, ration card number, bank account details, passport-size photograph, signature and left-hand thumbprint.

Candidates who wish to appear for the NEET exam have to meet all the eligibility criteria, which include being "between 17 and 25 years old, having passed Class 12 or equivalent with Physics, Chemistry, Biology or Biotechnology and English as core subjects from a recognised board," NDTV reported.

The NEET exam was delayed in 2020 due to the COVID-19 pandemic. It was held on 13 September amid strict protocol.

Over 13.66 lakh candidates appeared for NEET 2020. Out of which, 7,71,500 students qualified the exam.

With inputs from PTI



from Firstpost India Latest News https://ift.tt/30Egxzu
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more